Manuel Litchman MD - 31 Aug 2021 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role: President and CEO, Director
Signature: /s/ Manuel Litchman
Issuer symbol: MBIO
Transactions as of: 31 Aug 2021
Net transactions value: +$7,085
Form type: 4
Filing time: 24 Sep 2021, 17:23:31 UTC
Previous filing: 05 Aug 2021
Next filing: 08 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MBIO	COMMON STOCK	Award	$7,085	+2,746	+0.29%	$2.58	962,987	31 Aug 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period).
F2	Includes restricted stock units, which vest over various time periods.

Content

These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period).

Includes restricted stock units, which vest over various time periods.